PEG- RELIGRAST 6MG

About

Pegfilgrastim is a pegylated derivative of recombinant human granulocyte colony-stimulating factor (G-CSF), designed to provide a sustained duration of action compared to its non-pegylated counterpart, filgrastim. The pegylation process involves attaching polyethylene glycol molecules to the G-CSF, which significantly extends its half-life and allows for a single dose administration per chemotherapy cycle. This medication functions by stimulating the proliferation, differentiation, and activation of neutrophil precursors within the bone marrow, leading to an increased production and release of mature neutrophils into the bloodstream. Its primary clinical indication is to reduce the incidence of febrile neutropenia, a severe complication characterized by fever and low neutrophil counts, in patients with non-myeloid malignancies who are receiving myelosuppressive anti-cancer chemotherapy. This single-dose convenience helps to maintain neutrophil levels and minimize infection risk throughout the chemotherapy cycle.

Uses

• Chemotherapy-induced neutropenia
• Reduction of febrile neutropenia incidence
• Support during myelosuppressive chemotherapy
• Prevention of infection in cancer patients

Directions For Use

Administer a single subcutaneous injection per chemotherapy cycle, typically 24 hours after chemotherapy.

Benefits

• Convenient single dose per cycle
• Reduces incidence of febrile neutropenia
• Decreases risk of infection
• Supports on-schedule chemotherapy
• Maintains neutrophil counts
• Improves patient compliance

Side Effects

• Bone pain
• Myalgia
• Headache
• Fatigue
• Nausea
• Diarrhea
• Splenomegaly (rare)
• Allergic reactions
• Injection site reactions
• Leukocytosis
• Capillary leak syndrome (rare)
• Glomerulonephritis (rare)

Safety Measures

• Alcohol - No specific interaction, but alcohol can affect overall health during chemotherapy.
• Pregnancy - Use only if potential benefit justifies potential risk to fetus. Consult a doctor.
• Breastfeeding - Unknown if excreted in breast milk; use with caution. Consult a doctor.
• Liver - No specific dose adjustment needed, but monitor overall health.
• Kidney - No specific dose adjustment needed, but monitor overall health.
• Lung - Rare cases of acute respiratory distress syndrome (ARDS) reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.